Ernexa Therapeutics Inc. (ERNA) › Gross ProfitErnexa Therapeutics Inc. (ERNA): Gross ProfitAnnual figures by period end, from SEC filings.$486.0KYear ended 2024-12-312022-12-31: $02023-12-31: -$168.0K2024-12-31: $486.0K$486.0K2022-12-31 Gross Profit (USD) 2024-12-31Period endedGross ProfitChange YoYSource filing2024-12-31$486.0Kn/m2026-03-13, From 2024-01-012023-12-31-$168.0Kn/a2025-03-12, From 2023-01-012022-12-31$0n/a2024-03-14, From 2022-01-01Other metrics: RevenueCost of RevenueR&D ExpenseOperating IncomeDepreciation & AmortizationEBITDANet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesLong-Term DebtShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresFree Cash FlowShares OutstandingWeighted Average Diluted SharesEPS (Basic)